Summary B. Braun Melsungen AG (B. Braun) is a global health care company. It offers products and solutions for therapy fields and applications including acute dialysis, infusion therapy, apheresis, interventional vascular, diagnostics and treatment, cardio-thoracic surgery, laparoscopy, degenerative spine surgery, neurosurgery, diabetes, nutrition therapy, general open surgery, orthopedic joint replacement, hemodialysis, pain therapy, incontinence, stoma, infection prevention, and wound management. It has manufacturing facilities and R&D centers in the US, Europe and Asia. The company sells its products through a network of subsidiaries and associated companies in Europe, the Americas, Asia-Pacific, Africa and the Middle East. B. Braun is headquartered in Melsungen, Germany. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company B. Braun Melsungen AG - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons To Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 B. Braun Melsungen AG Company Snapshot 5 B. Braun Melsungen AG Company Overview 5 B. Braun Melsungen AG Pipeline Products and Clinical Trials Overview 6 B. Braun Melsungen AG - Pipeline Analysis Overview 8 Business Description 8 Key Facts 8 B. Braun Melsungen AG - Major Products and Services 9 B. Braun Melsungen AG Pipeline Products by Development Stage 13 B. Braun Melsungen AG Pipeline Products Overview 14 Biological Knee Regeneration Device 14 Biological Knee Regeneration Device Product Overview 14 Coroflex DEBlue 15 Coroflex DEBlue Product Overview 15 Needle-Free System 16 Needle-Free System Product Overview 16 B. Braun Melsungen AG - Key Competitors 17 B. Braun Melsungen AG - Key Employees 18 B. Braun Melsungen AG - Key Employee Biographies 19 B. Braun Melsungen AG - Locations And Subsidiaries 20 Head Office 20 Other Locations & Subsidiaries 20 Recent Developments 25 B. Braun Melsungen AG, Recent Developments 25 May 16, 2016: B. Braun to Showcase Its Innovative Synchronized Intelligence Infusion Platform at AACN 25 May 10, 2016: B. Braun Medical Calls for ECRI Institute to Establish a Scientific, Protocol-Driven Methodology for Evaluating Infusion Pumps 25 May 04, 2016: Dialog+ Hemodialysis Systems by B. Braun Medical: Class I Recall - Defective Conductivity Sensors 26 Mar 23, 2016: B. Braun's growth trend continues 26 Mar 18, 2016: B. Braun to Launch the Only Macro and Micro Compounder With 26-Lead Preassembled Sets 28 Mar 15, 2016: Aesculap agrees to participate in neuroloop and invest in a University of Freiburg spinoff 28 Dec 04, 2015: Change in B. Braun Management Board 29 Dec 04, 2015: B. Braun Medical to Showcase its Robust Pharmacy Portfolio at ASHP 29 Dec 03, 2015: B. Braun Medical Collaborates With First Databank to Offer Clinical Decision Support Resources 30 Nov 16, 2015: B. Braun Launches Ster-ASSIST 30 Appendix 32 Methodology 32 About GlobalData 32 Contact Us 32 Disclaimer 32
List of Tables
B. Braun Melsungen AG Pipeline Products and Clinical Trials Overview 6 B. Braun Melsungen AG Pipeline Products by Equipment Type 6 B. Braun Melsungen AG Pipeline Products by Indication 7 B. Braun Melsungen AG, Key Facts 8 B. Braun Melsungen AG, Major Products and Services 9 B. Braun Melsungen AG Number of Pipeline Products by Development Stage 13 B. Braun Melsungen AG Pipeline Products Summary by Development Stage 13 Biological Knee Regeneration Device - Product Status 14 Biological Knee Regeneration Device - Product Description 14 Coroflex DEBlue - Product Status 15 Coroflex DEBlue - Product Description 15 Needle-Free System - Product Status 16 Needle-Free System - Product Description 16 B. Braun Melsungen AG, Key Employees 18 B. Braun Melsungen AG, Key Employee Biographies 19 B. Braun Melsungen AG, Other Locations 20 B. Braun Melsungen AG, Subsidiaries 20
List of Figures
B. Braun Melsungen AG Pipeline Products by Equipment Type 7 B. Braun Melsungen AG Pipeline Products by Development Stage 13
Global non destructive testing equipment market is anticipated to reach USD 5.76 billion by 2022, as per a new research report by Radiant Insights, Inc. Stringent government safety initiatives for inspection and quality control across numerous industRead More...
Global sorbitol market size is anticipated to be reach USD 3.99 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing consumer perception towards product benefits derived from natural ingredients is expected to drive the demRead More...
Global amino acids market size is anticipated to be valued at USD 35.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in animal feed additive demand owing to regulate metabolism in livestock production owing to growiRead More...
Global coated fabrics market size forecast is estimated at USD 22.57 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing production of seat covers & airbags for automobile applications is likely to favor market growth.Read More...
Global heat transfer fluids market size is likely to be valued at USD 3.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing demand for for heat recovery management in industries such as metal processing, pharmaceuticaRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.